← Back to Analyst Consensus 
ABVX Buy
Abivax S.A.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Oct 20, 2026 | Guggenheim | reiterate | Buy → Buy | — | 52% |
| Sep 22, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Sep 22, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Sep 22, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 10, 2026 | Goldman Sachs | initiate | — → Buy | — | 54% |
| Sep 5, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jul 9, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Jul 2, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 1, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Jun 30, 2026 | Jefferies | upgrade | Hold → Buy | — | 52% |
| Jun 30, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Jun 30, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Jun 30, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 16, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 2, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jun 2, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Jun 2, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jun 2, 2026 | Wedbush | upgrade | Underperform → Neutral | — | 58% |
| Jun 2, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Jun 2, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 26, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Mar 24, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 16, 2026 | Jefferies | initiate | — → Buy | — | 52% |
| Feb 25, 2026 | BTIG | reiterate | Buy → Buy | $150 | 52% |
| Feb 24, 2026 | Wedbush | initiate | — → Underperform | $110 | 58% |
| Jan 9, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $145 | 54% |
| Jan 8, 2026 | BTIG | maintain | Buy → Buy | $150 | 52% |
| Dec 16, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $131 | 47% |
| Nov 24, 2025 | Truist Securities | initiate | — → Buy | $140 | 54% |
| Nov 6, 2025 | Wolfe Research | initiate | — → Outperform | $176 | 53% |
| Oct 13, 2025 | Barclays | initiate | — → Overweight | $142 | 53% |
| Oct 10, 2025 | Guggenheim | maintain | Buy → Buy | $150 | 52% |
| Oct 7, 2025 | BTIG | maintain | Buy → Buy | $120 | 52% |
| Sep 25, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $114 | 53% |
| Sep 12, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $101 | 54% |
| Sep 9, 2025 | BTIG | reiterate | Buy → Buy | $112 | 52% |
| Jul 29, 2025 | Piper Sandler | maintain | Overweight → Overweight | $112 | 54% |
| Jul 23, 2025 | Piper Sandler | maintain | Overweight → Overweight | $70 | 54% |
| Jul 23, 2025 | LifeSci Capital | maintain | Outperform → Outperform | $101 | 57% |
| Jul 23, 2025 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $71 | 54% |
| Jul 23, 2025 | Guggenheim | maintain | Buy → Buy | $101 | 52% |
| Jul 23, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $95 | 53% |
| Apr 30, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $33 | 53% |
| Mar 18, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $33 | 49% |
| Jan 10, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $33 | 53% |
| Dec 4, 2024 | JMP Securities | initiate | — → Market Outperform | $33 | 53% |
| Jul 29, 2024 | Laidlaw & Co. | initiate | — → Buy | $48 | 20% |
| May 20, 2024 | BTIG | initiate | — → Buy | $43 | 52% |
| Apr 29, 2024 | Guggenheim | initiate | — → Buy | $50 | 52% |
Price Target Trend
May 4, 2026 Latest: $163.58 Oct 24, 2026
EPS Estimates
+1q $-0.89
Lo: $-1.16 Hi: $-0.64
4 analysts 0q $-0.86
Lo: $-1.11 Hi: $-0.59
4 analysts ▲1
0y $-4.17
Lo: $-4.67 Hi: $-3.81
7 analysts +1y $-3.84
Lo: $-4.91 Hi: $-2.52
7 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days